Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction

Molecular Human Reproduction

Volumn 13, Issue 4, 2007, Pages 281-285

  Sziller, I ^a   Babula, O ^b   Hupuczi, P ^a   Nagy, B ^a   Rigo B ^a   Szabo G ^a   Papp, Z ^a   Linhares, I M ^b   Witkin, S S ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Gene polymorphism; HELLP syndrome; Intrauterine growth restriction; Mannose binding lectin; Pre eclampsia

Indexed keywords

DNA; MANNOSE BINDING LECTIN;

ADULT; ALLELE; ARTICLE; CODON; CONTROLLED STUDY; DELIVERY; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HELLP SYNDROME; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ADULT; CASE-CONTROL STUDIES; CODON; FEMALE; FETAL GROWTH RETARDATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELLP SYNDROME; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MANNOSE-BINDING LECTIN; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTORS;

EID: 34147187301     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam003     Document Type: Article

References (28)

1. Babula O, Danielsson I, Sjoberg I, Ledger WJ and Witkin SS (2004) Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 191,762-766.
2. Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW and Schmidt WM (2006) Evidence for an association between mannose-binding lectin 2 MBL2) gene polymorphisms and pre-term birth. Genet Med 8,518-524.
3. Bulla R, Bossi F, Agostini C and Tedesco F (2006) The multiple functions of the complement system in pregnancy. Am J Reprod Immunol 56,24-25. (Abstract)
4. Chakravarti A (1999) Population genetics - making sense out of sequence. Nat Genet 21,56-60.
5. Chappel S and Morgan L (2006) Searching for genetic clues to causes of pre-eclampsia. Clin Sci. 111,443-458.
6. Duckitt K and Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: Systemic review of controlled studies. BMJ 330,565-571.
7. Faulk WP, Jarret R, Keane M, Johnson PM and Boackle RJ (1980) Immunological studies of human placentae: Complement components in immature and mature chorionic villi. Clin Exp Immunol 40,299-305.
8. Feinberg BB (2006) Pre-eclampsia: The death of Goliath. Am J Reprod Immunol 55,84-98.
9. Fekete A, Vér Á, Bögi K, Treszl A and Rigó J Jr (2006) Is pre-eclampsia associated with higher frequency of Hsp70 gene polymorphism? Eur J Obstet Gynecol Reprod Biol 126,197-200.
10. Garred P, Madsen HO, Kurtzhals JAL, Lamm LU, Thiel S, Hey AS and Svejgaard A (1992) Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet 19,403-412.
11. Girardi G, Bulla R, Salmon JE and Tedesco F (2006) The complement system in the pathophysiology of pregnancy. Mol Immunol 43,68-77.
12. Hansen S and Holmskov U (1998) Structural aspects of collectins and receptors for collectins. Immunobiology 199,165-189.
13. Leung TF, Tang NL, Sung YM, Ma SL, Lam CW and Wong GW. (2006) Genetic association study between mbl2 and asthma phenotypes in Chinese children. Pediatr Allergy Immunol 17,501-507.
14. Madsen HO, Garred P, Kurzhals JA, Lamm LU, Ryder LP, Thiel S and Svejgaard S (1994) A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40,37-44.
15. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP and Svejgard A (1995) Interplay between promoter and structural gene variants controls basal serum level of manna-binding protein. J Immunol 155,3013-3020
16. Martin JN, Blake PG, Perry KG, McCaul JF, Hess LW and Martin RW (1991) The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 164,1500-1513.
17. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ and Turner MW (2000) Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68,688-693.
18. Redman CW and Sargent IL (2005) Latest advances in understanding pre-eclampsia. Science 308,1592-1595.
19. Papp C, Szabó G, Tóth-Pál E and Papp Z (1991) Fetal growth standards 1988-89. Orv Hetil 132,1865-1870 (in Hungarian).
20. Redman CW, Sacks GP and Sargent IL (1999) Pre-eclampsia: An excessive maternal response to pregnancy. Am J Obstet Gynecol 180,499-506.
21. Roberts JM and Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357,53-56.
22. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC and Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe pre-eclampsia-eclampsia. Am J Obstet Gynecol 155,501-509.
23. Sinha D, Wells M and Faulk WP (1984) Immunological studies of human placentae: Complement components in pre-eclamptic chorionic villi. Clin Exp Immunol 56,175-184.
24. Super M, Thiel S, Lu J, Levinsky RJ and Turner MW (1989) Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2,1236-1239.
25. Tedesco F, Radillo O, Candussi G, Nazzaro A, Mollnes TE and Pecorari D (1990) Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clin Exp Immunol 80,236-240.
26. Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40,423-429.
27. Vatten LJ and Skjaerven R (2004) Is pre-eclampsia more than one disease? BJOG 111,298-302.
28. Venkatesha S, Toporsian M, Lam C, Hanai JI, Mammotot T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Liberman TA et al. (2006) Soluble endoglin contributes to the pathogenesis of pre-eclampsia. Nat Medi 12,642-649.